EPHA7 (Human) IP-WB Antibody Pair
IP
Reaktivität: Human
IP
unconjugated
Wirt: Kaninchen, Maus
1 image
-
- Target Alle EPH Receptor A7 (EPHA7) Produkte
- EPH Receptor A7 (EPHA7)
- Reaktivität
- Human
- Wirt
- Kaninchen, Maus
- Applikation
- Immunoprecipitation (IP)
- Verwendungszweck
- This IP-WB antibody pair set comes with one antibody for immunoprecipitation and another to detect the precipitated protein in western blot.
- Kreuzreaktivität
- Human
- Produktmerkmale
- This IP-WB antibody pair set comes with one antibody for immunoprecipitation and another to detect the precipitated protein in western blot.
- Bestandteile
-
Antibody pair set content:
1. Antibody pair for IP: rabbit polyclonal anti-EPHA7 (300 μL)
2. Antibody pair for WB: mouse polyclonal anti-EPHA7 (50 μL)
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Handhabung
- Please aliquot to avoid repeated freeze thaw cycle.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store reagents of the antibody pair set at -20°C or lower. Please aliquot to avoid repeated freeze thaw cycle. Reagents should be returned to -20°C storage immediately after use.
-
- Target
- EPH Receptor A7 (EPHA7)
- Andere Bezeichnung
- EPHA7 (EPHA7 Produkte)
- Synonyme
- fc51g03 Matched Antibody Pair, wu:fc51g03 Matched Antibody Pair, si:dkey-23k6.1 Matched Antibody Pair, EHK3 Matched Antibody Pair, HEK11 Matched Antibody Pair, Cek11 Matched Antibody Pair, Ebk Matched Antibody Pair, Ehk3 Matched Antibody Pair, Hek11 Matched Antibody Pair, Mdk1 Matched Antibody Pair, CEPHA7 Matched Antibody Pair, EPH receptor A7 Matched Antibody Pair, eph receptor A7 Matched Antibody Pair, ephrin type-B receptor 1-B Matched Antibody Pair, Eph receptor A7 Matched Antibody Pair, EPHA7 Matched Antibody Pair, epha7 Matched Antibody Pair, LOC100166161 Matched Antibody Pair, Epha7 Matched Antibody Pair
- Sub Type
- Cocktail
- Hintergrund
-
Full Gene Name: EPH receptor A7
Synonyms: EHK3,HEK11 - Gen-ID
- 2045
-
Sie sind hier:
